U.S. Markets open in 1 hr 21 mins
  • S&P Futures

    4,382.00
    -29.75 (-0.67%)
     
  • Dow Futures

    34,863.00
    -111.00 (-0.32%)
     
  • Nasdaq Futures

    14,872.25
    -165.50 (-1.10%)
     
  • Russell 2000 Futures

    2,224.20
    -13.30 (-0.59%)
     
  • Crude Oil

    73.43
    -0.19 (-0.26%)
     
  • Gold

    1,831.40
    -4.40 (-0.24%)
     
  • Silver

    25.56
    -0.23 (-0.88%)
     
  • EUR/USD

    1.1896
    0.0000 (-0.0000%)
     
  • 10-Yr Bond

    1.2690
    0.0000 (0.00%)
     
  • Vix

    19.17
    +0.86 (+4.70%)
     
  • GBP/USD

    1.3961
    +0.0003 (+0.0223%)
     
  • USD/JPY

    109.6660
    +0.2050 (+0.1873%)
     
  • BTC-USD

    38,759.66
    -806.95 (-2.04%)
     
  • CMC Crypto 200

    920.88
    -9.48 (-1.02%)
     
  • FTSE 100

    7,020.24
    -58.18 (-0.82%)
     
  • Nikkei 225

    27,283.59
    -498.83 (-1.80%)
     

Is Editas the Best Genetics Stock to Buy?

·4 min read

There are some big opportunities in the gene editing space over the coming decades. In this Fool Live video clip, recorded on May 24, Fool.com Healthcare Bureau Chief Corrine Cardina, contributor Brian Orelli, PhD, and Chief Growth Officer Anand Chokkavelu discuss Editas Medicine (NASDAQ: EDIT) and why it could be a good stock to put on your radar. Editas has a strong pipeline further out.